SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-20-177698
Filing Date
2020-06-24
Accepted
2020-06-24 16:34:51
Documents
3
Group Members
DEERFIELD MANAGEMENT COMPANY, L.PDEERFIELD PRIVATE DESIGN FUND III, L.P.DEERFIELD PRIVATE DESIGN FUND IV, L.P.TORONTO TRANSACTION CORP

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d935954dsctota.htm SC TO-T/A 34995
2 EX-99.A.5.B d935954dex99a5b.htm EX-99.A.5.B 6339
3 EX-99.D.7 d935954dex99d7.htm EX-99.D.7 14937
  Complete submission text file 0001193125-20-177698.txt   58169
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Subject) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-87366 | Film No.: 20985839
SIC: 2834 Pharmaceutical Preparations

Mailing Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963
Business Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963 908 617-1309
MELINTA THERAPEUTICS, INC. /NEW/ (Filed by) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations